Ipath Series B Etf Profile

GRN Etf  USD 27.31  0.03  0.11%   

Performance

1 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
IPath Series is selling at 27.31 as of the 30th of November 2024; that is 0.11% increase since the beginning of the trading day. The etf's open price was 27.28. IPath Series has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for iPath Series B are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
The index has the objective of providing exposure to the price of carbon as measured by the return of futures contracts on carbon emissions credits from two of the worlds major emissions-related mechanisms. Ipath Series is traded on New York Stock Exchange in the United States. More on iPath Series B

Moving against IPath Etf

  0.39VZ Verizon Communications Sell-off TrendPairCorr
  0.35SLV iShares Silver TrustPairCorr
  0.34SIVR abrdn Physical SilverPairCorr
  0.31GLTR abrdn Physical PreciousPairCorr

IPath Etf Highlights

Thematic Ideas
(View all Themes)
Old Names[Green REIT PLC, Greenlane Renewables Inc, Greenalia S.A.]
Business ConcentrationWSE WIG INDEX, Warsaw WIG80 Index, Strategy ETFs, Alternative Energy, Theme ETFs, Commodities Focused, Barclays (View all Sectors)
IssuerBarclays Capital
Inception Date2019-09-11
BenchmarkBarclays Global Carbon II TR USD Index
Entity TypeExchange-Traded Note
Asset Under Management22.21 Million
Asset TypeEquity
CategoryStrategy
FocusTheme
Market ConcentrationDeveloped Markets
RegionGlobal
Fiscal Year End31-Dec
ExchangeNYSE Arca, Inc.
Market MakerJane Street
Country NameUSA
Returns Y T D(11.0)
NameiPath Series B Carbon ETN
Currency CodeUSD
Open FigiBBG00Q6YJRB9
In Threey Volatility35.66
1y Volatility35.54
200 Day M A26.1841
50 Day M A26.0363
CodeGRN
Updated At30th of November 2024
Currency NameUS Dollar
In Threey Sharp Ratio0.16
TypeETF
iPath Series B [GRN] is traded in USA and was established 2019-09-10. The fund is classified under Commodities Focused category within Barclays family. The entity is thematically classified as Strategy ETFs. iPath Series B currently have 122.13 M in assets under management (AUM). , while the total return for the last 3 years was -2.8%.
Check IPath Series Probability Of Bankruptcy

Sector Allocation

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on IPath Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding IPath Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as iPath Series B Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.

iPath Series B Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IPath Series. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

IPath Series Against Markets

When determining whether iPath Series B offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IPath Series' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ipath Series B Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ipath Series B Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iPath Series B. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.